ClinicalTrials.govpublic full text
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
schizophrenia, schizo-affective disorder, schizophreniform; schizophrenic, bipolar disorder i, bipolar disorder ii, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 803458
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.